My Cause, My Cleats: Lacing up to drive meaningful change
Breakthrough T1D is honored to have the support of nine NFL players, coaches, and staff for the 2025 My Cause, My Cleats initiative.
Hot off the press: Continuous ketone monitoring guidelines are here
What’s happening? Continuous ketone monitoring (CKM) is on its way. A new paper in The Lancet Diabetes & Endocrinology, titled “International expert recommendations on the application and utility of continuous ketone monitoring for people with diabetes,” was published by Breakthrough T1D and expert collaborators, spearheaded by our Chief Medical Officer, International, Thomas Danne, M.D., Ph.D. […]
Support and resources for your CGM
Support and resources for issues with continuous glucose monitors (CGMs), including inaccurate readings and faulty sensors.
2025 Top T1D advances: Full speed ahead
How quickly a year goes by—and a lot has happened for type 1 diabetes (T1D) in 2025! In these last few weeks leading up to the new year, Breakthrough T1D would like to take a moment to reflect on how far we’ve come in the past 365 days. Read on for the greatest T1D accomplishments […]
Smart devices, angry skin: The underside of diabetes tech
Skin reactions from adhesives on insulin pumps and CGMs are common. Learn why they occur and how to reduce irritation.
See Medical Affairs. See T1D.
Closing the gap between access to and adoption of type 1 diabetes therapies is a mission priority. Chris Dunn represents these efforts in action.
A week-long, intercontinental marathon journey for type 1 diabetes
Forrest Johnson embarked on a globe-spanning, 184-mile sprint with The Great World Race to fundraise for type 1 diabetes research.
See our advocates. See T1D.
Through grassroots support, Breakthrough T1D advocates help advance treatments, influence policy, and improve global access to care.
Cardiovascular disease and T1D: Advancing breakthroughs in Europe and beyond
What’s happening? Today, Breakthrough T1D co-hosted an event with leading international diabetes organizations to discuss cardiovascular disease (CVD) and type 1 diabetes (T1D)—where we are, challenges that remain, and how we can work together in Europe and beyond to address this need for the T1D community. The focus of the event: Doing more for CVD […]
Highlights from the 2025 ISPAD conference
Bonjour from Montreal, Canada, where the latest and greatest in type 1 diabetes (T1D) research was presented at the International Society for Pediatric and Adolescent Diabetes (ISPAD) 51st Annual Conference. ISPAD is a yearly highlight of the T1D conference calendar, and this year was no exception. Scientists, clinicians, researchers, industry members, people with diabetes, and […]
